Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1136/lupus-2020-000396 http://scihub22266oqcxt.onion/10.1136/lupus-2020-000396 32341791!7174058!32341791     free     free     free       Lupus+Sci+Med 2020 ; 7 (1): e000396 Nephropedia Template TP {{tp|p=32341791|t=2020. Thoughts on COVID-19 and autoimmune diseases |pdf=|usr=}}{{32341791}} gab.com Text Thoughts on COVID-19 and autoimmune diseases JO: Lupus Sci Med http://www.kidney.de/pget.php?&tw=1&pmid=32341791 #FOAvip Over the 2 months since coronavirus first appeared in China, cases have emerged on every continent, and it is clear that patients with autoimmune diseases might also be affected. Coronavirus disease 2019 (COVID-19) is a highly contagious viral illness with a mortality rate approaching 2%. Here we discuss the challenges that patients with autoimmune diseases might face and the information on using immunomodulatory therapies like chloroquine, tocilizumab and baricitinib to quench the cytokine storm in patients with very severe COVID-19 pneumonia. Twit Text FOAVip Thoughts on COVID-19 and autoimmune diseases ????Lupus Sci Med http://www.kidney.de/pget.php?&tw=1&pmid=32341791 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32341791 #FOAvip English Wikipedia <ref>{{Cite pmid|32341791}}</ref> Thoughts on COVID-19 and autoimmune diseases #MMPMID32341791 Askanase AD; Khalili L; Buyon JP Lupus Sci Med 2020[]; 7 (1): e000396 PMID32341791show ga Over the 2 months since coronavirus first appeared in China, cases have emerged on every continent, and it is clear that patients with autoimmune diseases might also be affected. Coronavirus disease 2019 (COVID-19) is a highly contagious viral illness with a mortality rate approaching 2%. Here we discuss the challenges that patients with autoimmune diseases might face and the information on using immunomodulatory therapies like chloroquine, tocilizumab and baricitinib to quench the cytokine storm in patients with very severe COVID-19 pneumonia. |*Immunomodulation[MESH] |Antibodies, Monoclonal, Humanized/therapeutic use[MESH] |Autoimmune Diseases/*complications/therapy[MESH] |Azetidines/therapeutic use[MESH] |Betacoronavirus[MESH] |COVID-19[MESH] |Chloroquine/therapeutic use[MESH] |Coronavirus Infections/*complications/*drug therapy[MESH] |Cytokine Release Syndrome[MESH] |Humans[MESH] |Hydroxychloroquine/therapeutic use[MESH] |Immunosuppression Therapy[MESH] |Pandemics[MESH] |Pneumonia, Viral/*complications/*drug therapy[MESH] |Purines[MESH] |Pyrazoles[MESH] |Rheumatology[MESH] |SARS-CoV-2[MESH]Thoughts on COVID-19 and autoimmune diseases (epmc).pdf DeepDyve Pubget Overpricing